Next Generation Ophthalmic Irrigating Solution Posterior Segment Study

Completed · Phase 3

Conditions studied: Eye Diseases

In brief

The purpose of this study is to evaluate the safety of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS PLUS for use during surgery for removal of epimacular membrane and vitrectomy.

Key facts

Study ID

NCT00333203

Run by

Alcon Research

People needed

369

Starts

2005-10-01

Expected to finish

2006-03-01

Last updated by the study team

2012-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients of any race and sex, with an epimacular membrane who would benefit from vitrectomy and membrane removal.
• Other protocol-defined inclusion criteria may apply.

You may not qualify if…

• Under 18 years of age.
• Other protocol-defined exclusion criteria may apply.

Where it is running

• United States — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.